Agenus Inc AGEN:NASDAQ

Last Price$2.68NASDAQ Previous Close - Last Trade as of 4:00PM ET 1/21/22

Today's Change-0.06(2.19%)
Bid (Size)$2.66 (11)
Ask (Size)$2.68 (4)
Day Low / High$2.68 - 2.81
Volume4.0 M
  • Latest Stories
  • Commentary and Analysis
--HC Wainwright Starts Agenus at Buy With $12 Price Target
7:04AM ET 12/16/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

Agenus Swings to Q3 Earnings as Revenue Increases; Shares Rise Pre-Bell
8:49AM ET 11/09/2021 MT Newswires

Agenus (AGEN) on Tuesday swung to Q3 earnings of $0.72 per share from a loss of $0.28 per share a year earlier. Three analysts polled by Capital IQ...

Update: Agenus to Withdraw Biologics License Application for Cervical Cancer Drug Candidate; Shares Slump
2:07PM ET 10/22/2021 MT Newswires

(Updates with share price in second paragraph) Agenus (AGEN) said Friday that it is withdrawing its biologics license application for cervical cancer drug...

Agenus to Withdraw Biologics License Application for Cervical Cancer Drug Candidate; Shares Fall Pre-Bell
9:22AM ET 10/22/2021 MT Newswires

Agenus (AGEN) said Friday it is withdrawing its biologics license application for cervical cancer drug candidate balstilimab at the recommendation of the...

Agenus to Receive $20 Million Payment from Bristol Myers Squibb for AGEN1777; Shares Up Pre-Bell
9:19AM ET 10/12/2021 MT Newswires

Agenus (AGEN) said Tuesday it has triggered a $20 million cash payment under its global licensing agreement with Bristol Myers Squibb (BMY) for AGEN1777 to...

Sector Update: Health Care Stocks Down to End Week
4:09PM ET 9/17/2021 MT Newswires

Health care stocks were drifting lower in late Friday trade, with the NYSE Health Care Index down 0.2%, while the SPDR Health Care Select Sector ETF (XLV)...

Sector Update: Health Care Stocks Mixed Premarket Friday
9:11AM ET 9/17/2021 MT Newswires

Health care stocks were mixed premarket Friday. The Health Care SPDR (XLV) was down 0.17% while the iShares NASDAQ Biotechnology Index (IBB) was 0.14%...

Agenus Says Cervical Cancer Combination Therapy Shows 'High' Response Rates in Phase 2 Trial
3:48AM ET 9/17/2021 MT Newswires

Agenus (AGEN) reported Friday final results from a phase 2 trial evaluating balstilimab in combination with zalifrelimab in patients with...

Insider Sell: Agenus
5:36PM ET 9/14/2021 MT Newswires

Garo H Armen, Director, Chairman, and CEO, on September 13, 2021, sold 82,107 shares in Agenus (AGEN) for $533,696. Following the Form 4 filing with the...

--B. Riley Raises Agenus' PT to $12 from $11, Says Continued Regulatory Progress to Drive Stock Price Performance; Keeps Buy Rating
8:58AM ET 9/07/2021 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...